Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Intercure Ltd INCR

Healthcare Cannabis
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INCR)

InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation

GlobeNewswire November 3, 2025

InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow

GlobeNewswire October 8, 2025

InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

GlobeNewswire September 19, 2025

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

PR Newswire May 1, 2025

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

PR Newswire February 12, 2025

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

PR Newswire December 20, 2024

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

GlobeNewswire August 29, 2024

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

Business Wire August 28, 2024

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference

Business Wire May 22, 2024
View More News ››

Opinion & Analysis (NDAQ:INCR)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:INCR)

TDR Small Cap Sunday

373 Views Premiered Sep 1, 2024 This week, research five small-cap stocks. Find out which ones we would buy and which ones we think...
Betteryear2 - September 2, 2024

InterCure Begins 2022 with Record Breaking First Quarter

Record revenue of $341 million in the first quarter of 2022 Adjusted EBITDA2 increased almost 110% year-over-year to...
Betteryear2 - May 16, 2022

to Acquire Multi-National Medical Cannabis Producer “Better”

Marking the First Major Consolidation in Pharmaceutical Grade Medical Cannabis Market Acquisition is Expected to ...
Betteryear2 - February 16, 2022

Expands Pharmacy Chain in Israel

With addition of four new pharmacies, InterCure’s dedicated chain GIVOL now has 20 ...
Betteryear2 - November 15, 2021

Record Third Quarter Financial Results

Seventh consecutive quarter of high double-digit, sequential revenue growth Annualized revenues run rate of $100 million Adjusted...
Betteryear2 - November 15, 2021

Record Preliminary Third Quarter Revenue of CAD$24 million

Achieved a number of firsts and records including: Seventh consecutive quarter of double-digit revenue growth Seventh consecutive...
Betteryear2 - October 25, 2021
View more Bullboard ››

Forsys Metals Corp

Forsys Metals Corp

Forsys Metals Corp. together with its subsidiaries, engages in the acquisition, exploration, and development of uranium ...
View More »